Clean Vision Corp - Annual Report: 2009 (Form 10-K)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2009
o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____ to _____
CHINA VITUP HEALTH CARE HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Nevada | 000-52489 | 45-0552679 | |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification Number) | |
| |||
108-1 Nashan Road Zhongshan District Dalian, P.R.C. | |||
(Address of principal executive offices) | |||
Registrants telephone number, including area code: 86-411-8265-3668 |
Securities registered under Section 12(b) of the Exchange Act:
None
Securities registered under Section 12(g) of the Exchange Act:
Common Stock, par value $0.0001
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act [ ] Yes [ X ] No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the
[ ] Yes [ X ] No
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X ] Yes [ ]No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Not Applicable.
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ] | Accelerated filer [ ] |
Non-accelerated filer [ ] (Do not check if a smaller reporting company) | Smaller reporting company [ X ] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of the last business day of the registrants most recently completed second fiscal quarter. $9,118,688.
As of March 29, 2009, the Company had 15,000,000 shares issued and outstanding.
2
PART I
ITEM 1.
BUSINESS.
Overview
China Vitup Health Care Holdings, Inc., a Nevada corporation (hereinafter China Vitup Nevada or the Registrant"), is a holding company which, through its wholly-owned subsidiaries and operating affiliates, is engaged in the business of providing healthcare services to customers in China. Presently, the Registrant has an affiliate relationship with a single medical clinic which is a 24,200 square foot facility located in Dalian, China, through which it offers integrated healthcare services designed specifically to fit the needs of the Chinese population. At the clinic in Dalian, the Registrants operating affiliate both monitors the health of its patients through regularly scheduled check-ups, and works to diagnose its patients different ailments and establish appropriate treatment procedures for such ailments. Since the facility in Dalian is primarily a preventative care facility, patients who require medical treatment which is more than preventative in nature are referred to hospitals and other health facilities.
Currently, the majority of medical care services throughout the Peoples Republic of China (the PRC) are provided by government sponsored medical institutions and organizations which are often times overcrowded, under staffed, and under supplied and which are not designed to offer preventative care. There are a limited number of private institutions providing medical care to PRC citizens, particularly citizens within the middle class. The Registrants goal is to modernize the current healthcare industry in China by providing Chinese citizens with individualized healthcare services and preventative care tailored specifically to their needs at private medical facilities throughout China. Due to the overcrowding and a high patient to doctor ratio that exists within the state sponsored medical facilities throughout China, the Registrant believes that the rapidly increasing middle class of China is interested in seeking viable alternatives to state sponsored medical facilities. The Registrant aims to provide these individuals with an alternative to state sponsored medical facilities in the form of highly modern and upscale medical facilities where the Registrants clients can go to have their health monitored on a regular basis.
PRC laws restrict foreign ownership of medical clinics and hospitals located in China. As a result, the Registrant does not directly carry on any business operations. To comply with PRC laws, the Registrant operates through a corporate structure consisting of subsidiaries, variable interest entities (VIE), and contractual arrangements. A VIE is a term used by the U.S. Financial Accounting Standards Board to describe a legal business structure whose financial support comes from another corporation which exerts control over the VIE. As noted above, all of the Registrants business operations are structured around subsidiaries, VIEs and contractual agreements. Through these contractual agreements the Registrant is able to exert effective control over its PRC operating affiliates and receive all of the economic benefits derived from the business operations of its PRC operating affiliates. In accordance with the specific contractual agreements, which are discussed below, the consolidated financial statements of the Registrant include all assets and liabilities and all revenues and expenses of our affiliate medical clinic located in Dalian, China. The following diagram, which is discussed in detail below, illustrates the Registrants corporate structure and the contractual arrangements that allow the Registrant to exert effective control over its PRC operating affiliates and receive all of the economic benefits derived from the business operations of its PRC operating affiliates.
3
* Information regarding the Officers and Directors of each entity listed above can be found in Item 5, below.
4
Business Development & Corporate Structure
Company
The Registrant was incorporated under the laws of Canada as Second Bavarian Mining Consulting Services, Inc. (Second Bavarian) on February 24, 2003. On August 10, 2004, Second Bavarian amended and restated its Articles of Incorporation to change its name to Tubac Holdings, Inc. (Tubac) and to change its domicile to the State of Wyoming. On September 15, 2006, Tubac formed a wholly-owned subsidiary in Nevada called China Vitup Health Care Holdings, Inc. On October 2, 2006, through the completion of a merger with its wholly-owned subsidiary, China Vitup Nevada, Tubac changed its domicile to the State of Nevada and changed its name to China Vitup Health Care Holdings, Inc. As a result of the merger, each share of Tubac was exchanged for one share of China Vitup Nevada; Tubac ceased to exist as a separate entity and China Vitup Nevada continued as the surviving company.
Wholly-Owned Subsidiaries
China Vitup Healthcare Holdings, Inc.
On November 15, 2006 the Registrant completed the closing under an Agreement for Share Exchange with China Vitup Healthcare Holdings, Inc., (China Vitup BVI) a British Virgin Islands corporation, and the shareholders (the Shareholders) of China Vitup BVI. Under the terms of the Agreement for Share Exchange, the Registrant issued a total of 13,460,202 shares of its common stock in exchange for 50,000 shares of China Vitup BVI, representing 100% of the issued and outstanding common stock of China Vitup BVI (the Share Exchange). Upon completion of the Share Exchange, China Vitup BVI became a wholly owned subsidiary of the Registrant. China Vitup BVI is a holding company that was established on June 29, 2006 to facilitate the operation of our affiliate medical clinic located in Dalian, China.
Dalian Vitup Management Holdings Co., Ltd.
As a holding company, China Vitup BVI owns 100% of the capital stock of Dalian Vitup Management Holdings Co., Ltd., (Dalian Vitup Management) a wholly owned foreign enterprise formed under the laws of the PRC on August 30, 2006. Dalian Vitup Management is a holding company which was established for the purposes of facilitating the Registrants business operations in the PRC.
Due to PRC laws governing foreign ownership and investment in medical clinics in the PRC, Dalian Vitup Management does not directly own the entities in China through which the Registrants business operations are conducted. Instead, Dalian Vitup Management controls those entities and their business operations through a series of exclusive contractual agreements which are more fully described below. The contractual agreements are with the following variable interest entities and individuals: i) Dalian Vitup Healthcare Management Co., Ltd., (Dalian Vitup Healthcare) a limited liability company formed under the laws of the PRC on March 4, 2004; ii) Dalian Zhongshan Vitup Clinic (Dalian Vitup Clinic), a business which was registered as a sole-proprietorship under the laws of the PRC on January 10, 2006; and iii) Shubin Wang and Feng Gu, the sole shareholders of Dalian Vitup Healthcare.
Variable Interest Entities
5
Dalian Vitup Healthcare
Dalian Vitup Healthcare is a limited liability company that was formed under the laws of the PRC on March 4, 2004 with a registered capital of Renminbi Yuan (RMB) 8,000,000 (approximately US $970,756) provided by ShuBin Wang, one of our directors and our majority shareholder. On March 6, 2004 Dalian Vitup Healthcare began providing medical services to Chinese citizens on an annual basis. On September 1, 2006, Dalian Vitup Healthcare entered into the contractual agreements, all of which are discussed below, which established it as an operating affiliate of Dalian Vitup Management.
Dalian Vitup Clinic
The Dalian Vitup Clinic is a sole proprietorship that was registered under the laws of the PRC on January 10, 2006 with a registered capital of RMB 100,000 (approximately US $12,134), by ShuBin Wang, one of our directors and our majority shareholder; Shubin Wang is the sole proprietor and owner of the Dalian Vitup Clinic. In anticipation of becoming an affiliated entity with a publicly reporting company with the Securities and Exchange Commission, on or around April 1, 2006, Shubin Wang entered into a Shift Contract (the Shift Contract), discussed below, with Dalian Vitup Healthcare; the Shift Contract is one of the control agreements established to create our corporate structure. On September 1, 2006, Shubin Wang, as the sole proprietor of the Dalian Vitup Clinic entered into various other contractual agreements, which, together with the Shift Contract, made the Dalian Vitup Clinic an operating affiliate of Dalian Vitup Management. The Shift Contract, and the other contractual agreements are discussed below.
Contractual Agreements
As noted above, the Registrant does not directly carry on any business operations due to PRC laws and does not have a direct ownership interest in Dalian Vitup Healthcare or the Dalian Vitup Clinic through which business operations are conducted. However, through a series of contractual arrangements entered into by its wholly-owned subsidiary, the Registrant is able to: i) exert effective control over its PRC operating affiliates; ii) receive all the economic benefits derived from the business operations of its PRC operating affiliates, which in turn flow to the Registrant; and iii) have an exclusive option to purchase all or part of the equity interests in Dalian Vitup Healthcare.
The specific contractual agreements that allow the Registrant to exert effective control over its operating affiliates and receive all the economic benefits of the business activities of Dalian Vitup Healthcare and the Dalian Vitup Clinic are as follows: 1) a Loan Agreement; 2) a Share Pledge Contract; 3) an Exclusive Option Contract; 4) a Proxy Agreement; 5) an Amended Consulting Agreement; and 6) a Shift Contract (collectively referred to as the Control Agreements). The following is a summary of the Control Agreements:
Loan Agreement
On September 1, 2006 ShuBinWang and Feng Gu entered into the Loan Agreement (Loan Agreement) with Dalian Vitup Management for the purpose of implementing the Registrants VIE structure.
Pursuant to the terms of the Loan Agreement:
6
·
Dalian Vitup Management loaned ShuBin Wang and Feng Gu RMB 8,000,000 (approximately US $970,756).
·
The loan is a non-interest bearing loan that is payable at will by ShuBin Wang and Feng Gu; the term payable at will means the loan does not have a maturity date; The loan is currently outstanding.
·
The term of the Loan Agreement is from the disbursement date of the loan to the date of full repayment of the loan. Because the loan is payable at will by ShuBin Wang and Feng Gu, the Loan Agreement does not have a specific termination date.
·
Notwithstanding the foregoing, Dalian Vitup Management may demand full payment on the loan if any of the following events occur: i) ShuBin Wang or Feng Gu are fired or dismissed from Dalian Vitup Management or any of Dalian Vitup Managements affiliates; ii) either ShuBin Wang or Feng Gu die or become incapacitated; iii) either ShuBin Wang or Feng Gu engage in or are involved in criminal conduct; iv) any third party files a claim against ShuBin Wang or Feng Gu in excess of RMB 100,000 (approximately US $13,215); or v) Dalian Vitup Management chooses to exercise its right to purchase the shares of Dalian Vitup Healthcare pursuant to its rights under the Exclusive Option Contract, which is more fully described below. Aside from the foregoing, there are no events that would provide Dalian Vitup Management with the authority to demand immediate full repayment of the loan.
·
The loan is secured by ShuBin Wang and Feng Gus shares of stock in Dalian Vitup Healthcare through the Share Pledge Contract discussed below.
·
ShuBin Wang and Feng Gu may not, without the prior written consent of Dalian Vitup Management, sell, transfer, mortgage, pledge, dispose of by any other means or place any other secured rights on its shares and interests in Dalian Vitup Health Care.
·
Upon the full repayment of the balance of the loan, ShuBin Wang and Feng Gu are required to transfer 100% of their shares of stock in Dalian Vitup Healthcare, amounting to 100% of the capital stock of Dalian Vitup Healthcare, to Dalian Vitup Management, or a party designated by Dalian Vitup Management, in accordance with the laws of the PRC.
Share Pledge Contract
The Share Pledge Contract, dated September 1, 2006, is by and among Dalian Vitup Management, ShuBin Wang, Feng Gu, and Dalian Vitup Healthcare. Pursuant to the terms of the Share Pledge Contract:
·
ShuBin Wang and Feng Gu have pledged all of their equity interest in Dalian Vitup Healthcare, which amounts to 100% of Dalian Vitup Healthcare, to Dalian Vitup Management to secure their obligations under the relevant contractual control agreements, including but not limited to, their repayment obligations under the Loan Agreement.
·
ShuBin Wang and Feng Gu have each agreed not to transfer, sell, pledge or otherwise dispose of or create any encumbrance on their equity interest in Dalian Vitup Healthcare without the consent of Dalian Vitup Management.
·
The Share Pledge Contract terminates upon ShuBin Wang and Feng Gus fulfillment of their respective obligations under the Loan Agreement. However, as noted above, pursuant to the terms of the Loan Agreement, upon the full repayment of the balance of the loan, ShuBin Wang and Feng Gu are required to transfer 100% of their shares of stock in Dalian Vitup Healthcare, amounting to 100% of the capital stock of Dalian Vitup Healthcare, to
7
Dalian Vitup Management, or a party designated by Dalian Vitup Management, in accordance with the laws of the PRC.
Exclusive Option Contract
The Exclusive Option Contract, dated September 1, 2006, is by and among Dalian Vitup Management, ShuBin Wang, Feng Gu, and Dalian Vitup Healthcare. Pursuant to the terms of the Exclusive Option Contract:
·
Dalian Vitup Management may, in its sole and absolute discretion, elect to purchase 100% of the stock owned by ShuBin Wang and Feng Gu in Dalian Vitup Healthcare, which amounts to 100% of the capital stock of Dalian Vitup Healthcare.
·
The Exclusive Option Contract provides that the price at which Dalian Vitup Management can purchase all of ShuBin Wangs and Feng Gus interest in Dalian Vitup Healthcare shall be equal to the actual capital contributions that ShuBin Wang and Feng Gu paid for the option shares. The aggregate capital contributions that ShuBin Wang and Feng Gu have paid for the option shares is US $1,000,000; therefore, the price at which Dalian Vitup Management can purchase all of Mr. Wangs and Ms. Gus interest is US$1,000,000. There are no current PRC laws in effect that would require any type of appraisal to determine the stock price of the option shares; however, in the event that PRC law were to require an appraisal to determine the stock price of the option shares, the parties agree that the purchase price shall be the lowest price allowed under the applicable laws.
·
Neither ShuBin Wang, Feng Gu, nor Dalian Vitup Healthcare may enter into any transaction that could materially affect Dalian Vitup Healthcares assets, liabilities, equity or operations without the prior written consent of Dalian Vitup Management.
·
Neither ShuBin Wang, Feng Gu, nor Dalian Vitup Healthcare will distribute any dividends without the prior written consent of Dalian Vitup Management.
·
Dalian Vitup Management, and/or its designee, has an exclusive option to purchase all of ShuBin Wang and Feng Gus interest in Dalian Vitup Healthcare; such interest comprises 100% of the Dalian Vitup Healthcare.
·
The Exclusive Option Contract terminates upon the fulfillment of ShuBin Wang and Feng Gus obligations under the Loan Agreement. However, as noted above, pursuant to the terms of the Loan Agreement, upon the full repayment of the balance of the loan, ShuBin Wang and Feng Gu are required to transfer 100% of their shares of stock in Dalian Vitup Healthcare, amounting to 100% of the capital stock of Dalian Vitup Healthcare, to Dalian Vitup Management, or a party designated by Dalian Vitup Management, in accordance with the laws of the PRC.
Proxy Agreement
The Proxy Agreement, dated September 1, 2006, is by and among ShuBin Wang, Feng Gu and Dalian Vitup Management. Pursuant to the terms of the Proxy Agreement:
·
ShuBin Wang and Feng Gu granted Dalian Vitup Management full power and authority regarding any matters that require shareholder action as a result of ShuBin Wang and Feng Gus ownership interest in Dalian Vitup Healthcare; ShuBin Wang, the President and
8
Chairman of the Board of Directors of Dalian Vitup Management, has the authority to act on behalf of, and make decisions for, Dalian Vitup Management.
·
The Proxy Agreement terminates upon the repayment of the loan by ShuBin Wang and Feng Gu pursuant to the terms of the Loan Agreement discussed above.
Amended Consulting Agreement
On September 1, 2006, Dalian Vitup Management entered into a Consulting Agreement with Dalian Vitup Healthcare. The Consulting Agreement was subsequently amended to further clarify Dalian Vitup Managements right to receive substantially all of the economic interest of Dalian Vitup Healthcare. The Amended Consulting Agreement, dated July 7, 2008, is by and among Dalian Vitup Management, and Dalian Vitup Healthcare. Pursuant to the terms of the Amended Consulting Agreement:
·
Dalian Vitup Management will provide exclusive consulting services for Dalian Vitup Healthcare regarding: 1) services relating to health management; 2) services relating to the associate products in health management; 3) staff training; and 4) all other services required by Dalian Vitup Healthcare.
·
Dalian Vitup Healthcare pays Dalian Vitup Management a quarterly consulting fee of RMB 250,000 (approximately US $34,456).
·
Dalian Vitup Healthcare pays Dalian Vitup Management 90% of the net profit generated by Dalian Vitup Healthcare.
·
Dalian Vitup Healthcare pays Dalian Vitup Management technical services fees computed on an hourly basis for services rendered by Dalian Vitup Management, the pricing of which are determined by mutual agreement of the parties.
·
Subject to certain early termination provisions, the Amended Consulting Agreement is for an indefinite term and shall remain in full force and effect for the entire time period that Dalian Vitup Management remains in business. Notwithstanding the foregoing: i) Dalian Vitup Healthcare may terminate the Amended Consulting Agreement if Dalian Vitup Management commits a gross fault, fraudulent or other illegal act, or becomes bankrupt; and ii) Dalian Vitup Management may terminate the Amended Consulting Agreement upon 30 days prior notice to Dalian Vitup Healthcare at any time.
Dalian Vitup Clinics Property Rights and Interests Shift Contract (the Shift Contract)
The Shift Contract dated April 1, 2006, is by and among ShuBin Wang and Dalian Vitup Healthcare. Pursuant to the terms of the Shift Contract:
·
The parties agree and acknowledge that Dalian Vitup Healthcare is the beneficiary of all of titles of the property, rights and interests of Dalian Zhongshan Vitup Clinic.
·
The parties agree and acknowledge that the Dalian Vitup Clinic shall be managed and controlled by Dalian Vitup Healthcare.
·
The parties agree and acknowledge that Dalian Vitup Clinic is not an independent entity and that its revenue and income shall be consolidated with the financial statements of Dalian Vitup Healthcare.
·
The Shift Contract is for an indefinite term and may only be revised or terminated upon the mutual consent of both parties to the Contract.
9
The Shift contract ensures that Dalian Vitup Healthcare is the beneficiary of all of the property, rights, and interests of the Dalian Vitup Clinic, of which Shubin Wang is the sole owner. Dalian Vitup Healthcare is relying upon the Shift Contract as the mechanism through which it will be entitled to control the operations of Dalian Vitup Clinic and to receive all the economic benefits of the business operations of Dalian Vitup Clinic. We believe no proxy agreement or option agreement is necessary because ShuBin Wang, as sole owner of Dalian Vitup Clinic, has shifted all the clinics property, rights and interests to Dalian Vitup Healthcare pursuant to the terms of the Shift Contract. We believe no consulting agreement requiring payment of consulting fees is required because, in accordance with the terms of Shift Contract, the parties have acknowledged that Dalian Vitup Clinic is not an independent entity and that its revenue and income are to be considered with Dalian Vitup Healthcare. The other control agreements, discussed above, provide Dalian Vitup Management with control over Dalian Vitup Healthcare.
The foregoing description of the Control Agreements is qualified in its entirety by reference to the Loan Agreement, Share Pledge Contract, Exclusive Option Contract, and Proxy Agreement which were filed as Exhibits 10.1, 10.2, 10.3, and 10.4, respectively, to the Companys Form 10 filed with the Securities and Exchange Commission on May 1, 2008, and are herein incorporated by reference, and the Amended Consulting Agreement, and Shift Contract, which were filed as Exhibits 10.14 and 10.6, respectively, to the Companys Amendment No. 1 on Form 10/A with the Securities and Exchange Commission on July 23, 2008 and are herein incorporated by reference.
The Registrant believes that: (i) its corporate structure is in compliance with existing PRC Laws and regulations regarding foreign investment in the PRC medical industry; (ii) the contractual arrangements among Dalian Vitup Management, Dalian Vitup Healthcare, Dalian Vitup Clinic, ShuBin Wang and Feng Gu are valid, binding and enforceable and will not result in any violation of PRC laws or regulations currently in effect; and (iii) the business operations described herein are in compliance with existing PRC laws and regulations in all material respects. However, there are substantial uncertainties regarding the interpretation and application of current and future PRC laws and regulations. Accordingly, there can be no assurance that the PRC regulatory authorities will not in the future take a view that is contrary to the current opinion about the legality of our corporate structure. Furthermore, if the PRC government finds the agreements that establish the structure for operating our medical services business do not comply with PRC government restrictions on foreign investment in medical institutes, we could be subject to penalties.
Business of Issuer
As noted above, the Registrant is not an operating business. All of the business operations of the Registrant are conducted through its wholly-owned subsidiaries and its operating affiliates. As used in this Form 10-K, unless otherwise specifically noted, from this point forward all references to the Company, we, our and us refer to the Registrant, and its wholly owned subsidiaries, China Vitup BVI and Dalian Vitup Management. All references to operating affiliate unless otherwise specifically noted, collectively refers to Dalian Vitup Healthcare and the Dalian Vitup Clinic.
Currently, the majority of medical care services throughout the PRC are provided by government sponsored medical institutions and organizations which are often times overcrowded, under staffed, and under supplied. Consequently, there are a limited number of private institutions providing medical care to PRC citizens, particularly citizens within the middle class. The Companys goal is to modernize the current healthcare industry in China by providing Chinese citizens with individualized healthcare services tailored specifically to their needs at private medical facilities throughout China. Due to the overcrowding and high patient to doctor ratio that exists within the state sponsored medical facilities throughout China, we believe
10
that the rapidly increasing middle class of China is interested in seeking viable alternatives to state sponsored medical facilities. Through our operating affiliates, the Company aims to provide these individuals with an alternative to state sponsored medical facilities in the form of highly modern and upscale medical facilities where their clients can go to have their health monitored on a regular basis.
Currently, our operating affiliate offers integrated health management services designed specifically for the PRC population through its preventative care medical facility located in the city of Dalian, China. The Companys health services offered at its operating affiliates medical facility include physical examinations, health management plans, and guidance for medical treatment. Our operating affiliate assists its patients in maintaining a healthy status by comprehensively monitoring, analyzing and evaluating the patients and by predicting various risk factors that affect the health and well being of its patients. In many instances, the Dalian Vitup Clinic, as a primary checkup facility, will refer its patients to specialized hospitals and health facilities throughout the world which are equipped to treat the patients specific health problems and needs that the have been identified through a comprehensive checkup and monitoring procedures.
Our operating affiliates primary technique for evaluating and monitoring the health of its patients is through the implementation of its four-dimensional checkup model (the Model). The Model consists of a blend of standard western medical checkup procedures, psychological evaluations, traditional Chinese medical consultations, and life style evaluations. The western aspect of the Model utilizes standard western medical procedures to evaluate and monitor the health of patients, including, but not limited to, the following checkup procedures: tumor screening, blood testing, ultra sound examinations, ophthalmic inspection, and oral cavity checkups. In addition to the western aspect of the Model, our operating affiliate performs comprehensive psychological tests on its patients to assist them in determining life orientation and career choices. The traditional Chinese medical aspect of the Model focuses on the utilization of standard Chinese medical methods to evaluate a patients health. Standard Chinese medical methods focus on a medical approach of monitoring and palpating the patients body to diagnose potential health problems that a patient may have, as well as prescribing herbal medications to address any health problems that a patient is experiencing. The final component of the Model is the nutritional evaluation. Our operating affiliate uses various advanced technologies to analyze a patients body composition and ultimately establish nutritional programs geared towards the prevention of potential health problems.
Currently, our operating affiliate operates a 24,200 square foot medical clinic and pharmacy in Dalian, China, and a mobile medical clinic which is based out of the medical facility located in Dalian. In conjunction with its medical facilities, our operating affiliate operates a 24 hour emergency medical hotline. Through this service clients may call in for 24 hour assistance regarding any of their medical issues.
Additionally, as noted above, our operating affiliate, Dalian Vitup Clinic, operates a referral program through which it refers our existing patients to domestic hospitals in the event they are in need of medical services which are not provided by the operating affiliate.
The Company has cooperative arrangements with several hospitals located throughout Beijing for the referral of patients who are in need of medical services which are not provided by the Company at its medical clinic. In order to establish a cooperative relationship with a hospital, the Company executes a standard Cooperation Agreement which provides that: i) the hospital will provide high quality medical services to the Companys clients; ii) the Company will provide all relevant medical information regarding the Companys client to the hospital, which the hospital will keep confidential; and; iii) the Company will,
11
based upon the fee-charging standard approved by the State, take responsibility for the payment of medical service expenses incurred by its client whom it referred to the hospital. Each Cooperation Agreement is valid for a term of three years and may be extended through negotiation of the parties to the Cooperation Agreement. The foregoing description of the Companys standard Cooperation Agreement is qualified in its entirety by reference to the Cooperative Agreement which was filed as Exhibit 10.7 to the Companys Form 10 filed with the Securities and Exchange Commission on May 1, 2008, and is herein incorporated by reference. In addition to the cooperative arrangement with hospitals located in China, the Company has cooperative arrangements with several international hospitals located in Japan for the referral of the Companys patients. The Companys international referral program is another service that the Company, through its operating affiliate, Dalian Vitup Clinic, provides to its patients. Through the referral program, the Dalian Vitup Clinic may refer patients to different international medical facilities to ensure that patients receive all necessary medical treatment. The international referral program is not a material part of the Companys business operations; rather, it is an additional service that the Company is able to provide through its operating affiliates to its patients to ensure that all of their medical needs are satisfied.
Additionally, our operating affiliates plan on developing referral based strategic alliances through close relationships with individuals in Japan, the United Kingdom, and Canada. These strategic alliances will be designed to assist the Company and its operating affiliate with the acquisition and importation of medical equipment and products. The purpose of these alliances will be to facilitate our operating affiliates international patient referral program and promote the Companys brand name to international businesses operating within the PRC. Neither the Company nor its operating affiliates have rendered any referral services over the last two years. We anticipate that the strategic alliances that we plan to enter into will facilitate the Companys knowledge and understanding regarding current trends and advancements with medical equipment and products. It is anticipated that the information garnered through these alliances with help influence the Companys decision on what medical equipment and products it will seek to acquire and have delivered to its offices in China. Furthermore in accessing what medical equipment and products to pursue, the Company will then take into consideration the domestic market and its customers needs. Moreover, if the Companys customers have the need of medical treatment which can not be satisfied by domestic hospitals, or if the Companys customers are abroad and need medical help, the Company anticipates utilizing strategic alliances to refer the customers to other hospitals located in foreign countries.
As noted above, the private healthcare industry is a small, but expanding, area of business in the PRC. We believe that we will be able to fill an existing void in the PRC healthcare system by offering preventative care and providing the citizens of the PRC with an alternative to state sponsored medical facilities for their regular medical checkups. Furthermore, by establishing relationships with existing health care facilities, we will be able to effectively and efficiently refer our patients to more advanced treatment centers to accommodate all of our patients medical needs.
Within the next three years, our objective is to establish additional medical clinics throughout China through which we are able to provide high quality medical care to Chinese citizens. We currently have plans to establish affiliate medical clinics in the following cities, in the following order: 1) Beijing; 2) Shenyang; 3) Dalian Development Zone. At the proper time, we are going to copy our business model quickly and open more new clinics in economically well developed cities all around China.
To facilitate our growth strategy, we have established a corporate headquarters and management team in Beijing to make the necessary preparations for the establishment of the additional affiliate medical
12
facilities throughout China. The management team will work to establish standards for all of our facilities and to create and implement a unified employee orientation and training program. The management team located in Beijing will supervise the development of all additional facilities.
Customers and Marketing
Customers
Due to the overcrowding and high patient to doctor ratios that exist within the state sponsored medical facilities throughout China, we believe that the rapidly increasing middle class of China is interested in seeking viable alternatives to state sponsored medical facilities. We aim to provide these individuals with an alternative to state sponsored medical facilities in the form of highly modern and upscale medical facilities where their clients can go to have their health monitored on a regular basis. Additionally, we aim to establish a venue whereby Chinese citizens can establish and maintain lasting relationships with primary care physicians.
Our operating affiliates current customers, all of whom are discussed in detail below, are composed mainly of the following: i) Enterprises; ii) Government Agencies; iii) Financial Agencies & Insurance Companies; iv) Members; and v) Individuals.
Enterprises
Our operating affiliate has established relationships with over thirty different business enterprises in China, both national and international. These enterprises have enlisted the services of our operating affiliate to have it provide health checkups for the enterprises employees. As we expand, we intend to solidify existing relationships between our customers and our operating affiliates, as well as establish new relationships, with other business enterprises in an effort to provide for the healthcare needs of business enterprises throughout China.
Government Agencies
A significant percentage of civil servants in China are required to have annual routine health checkups. Our operating affiliate has established relationships with various governmental agencies through which the agencies have agreed to designate our operating affiliate as the medical checkup institute to perform the annual exams on the respective agencies employees. The government agencies pay an annual fee for this service. Our operating affiliate currently has approximately 40 governmental agencies that it works with.
Financial Agencies & Insurance Companies
Our operating affiliate cooperates with various financial agencies and life insurance companies to provide the standard health checkup the financial agencies employees and potential life insurance candidates must undergo. The financial agencies and insurance companies pay all of the checkup expenses. These expenses are paid on a case-by-case basis at the time the checkup is performed.
Members
13
Members are identified as patients who have enlisted the services of our operating affiliate to monitor their health for a prolonged period. The Members pay a flat fee which entitles the Members to access to our operating affiliates medical services for a prescribed period, including an annual check-up. Our operating affiliate has identified Members as one of its most lucrative potential client bases. As such, our operating affiliate intends to focus significant efforts in rapidly increasing the number of Members.
As of July 1, 2008 our operating affiliate began to offer the following types of membership packages: (1) The Gold Package The Gold Package entitles the Member to medical services and health monitoring for a period of one year at an price of 100,000 RMB (approximately US $14,562); this package provides members with annual health check-ups and priority access to our operating affiliates facilities and medical staff over members who participate in the Silver Package discussed below; and (2) The Silver Package The Silver Package entitles the Member to medical services and health monitoring for a period of one year at a price of 20,000 RMB (approximately US $2,912.00); this package provides members with annual health check-ups and access to our operating affiliates facilities and medical staff. The major difference between each of the foregoing packages is the amount and frequency of medical services provided to the different types of members. For example, under the Gold Package, a member is entitled to 4 personalized health checkups during the course of the year, while the member who subscribes to the Silver Package is entitled to 1 personalized health checkup during the year. Additional differences are as follows: i) under the Gold Package a member is afforded 24 hour access to our operating affiliates consultation service and is entitled to 13 house visits by our operating affiliates physicians; ii) under the Silver Package a member is afforded access to our operating affiliates consultation service during business hours, and is entitled to 3 house visits by our operating affiliates physicians. As noted above, the major difference between the two packages is the amount and frequency of medical services provided to the different types of members.
Individuals
Individuals are classified as patients who have come to the clinic for a one-time health checkup. Our operating affiliates offer a variety of Individual Checkup Packages depending upon the Individuals age. Currently, approximately 7,424 individuals have participated in a one-time checkup.
Percentage of Revenue Attributable to Each Customer Type for Fiscal Years Ended 2008 and 2009
For the fiscal period that ended December 31, 2008, the foregoing customers accounted for the following percentages of the Companys revenue from its business operations conducted at its affiliate medical clinic located in Dalian: Individuals and Members 21%; Enterprises 72%; Insurance Companies 2%; and General Treatment 5%.
For the fiscal period that ended December 31, 2009, the foregoing customers accounted for the following percentages of the Companys revenue from its business operations conducted at its affiliate medical clinic located in Dalian: Individuals and Members 38%; Enterprises 56% and General Treatment 6%.
The following chart illustrates the changes which occurred regarding the percent and amount of the Companys revenue attributable to each customer type for the fiscal years ended 2009 and 2008
14
| Fiscal Years Ended 2008 and 2009 | |||||
Customer Type | 2009 ($) | % of Total | 2008 ($) | % of Total | Change | % Change |
Individuals & Members | 907,013 | 38% | 427,742 | 21% | 479,271 | 112% |
Enterprises (including Government Agencies) | 1,364,223 | 56% | 1,458,694 | 72% | -94,471 | -6% |
Insurance Companies | 0 | 0% | 38,504 | 2% | -38,504 | -100% |
General Treatment | 139,807 | 6% | 108,216 | 5% | 31,591 | 29% |
TOTAL | 2,411,043 | 100% | 2,033,156 | 100% | 377,887 | 19% |
Marketing
The Company intends to promote and market its brand name and services offered at its affiliate clinic in Dalian, as well as its future clinics through: 1) billboard advertisements on major arterial roads; 2) television advertisements; 3) newspaper and print advertisements; 4) electronic advertisements on the internet and the Companys website; 5) large public events promoting the various clinics and services that are offered; 6) distribution of promotional literature promoting and advertising the clinics; and 7) and foreign advertising.
Competition
Currently, the majority of medical care services throughout the PRC are provided by government owned medical institutions and organizations which are often times overcrowded, under staffed, and under supplied. Consequently, there are a limited number of private institutions providing medical care to PRC citizens, particularly citizens within the middle class. The Companys goal is to modernize the current healthcare industry in China by providing Chinese citizens with individualized healthcare services tailored specifically to their needs at private medical facilities throughout China.
As noted above, the Companys only affiliated operational medical clinic is located in the city of Dalian. Currently, within the four districts of Dalian there are 12 state sponsored hospitals and one state sponsored medical check-up facility. With the exception of our affiliate clinic in Dalian, there are no other private medical facilities in the city.
Intellectual Property
The Company does not own any trademarks or patents on any of the products that its operating affiliates sell, or methods that these operating affiliates utilize in their medical clinics. There may be patents issued or pending that are held by others and cover significant parts of our business methods or services. We cannot be certain that our products or business methods do not or will not infringe on any valid patents, copyrights or other intellectual property rights held by third parties. We may be subject to legal proceedings and claims, from time to time, relating to the intellectual property of others in the ordinary course of our business.
In addition, we may license products or technology from third parties. The market is evolving and we may need to license additional products or technologies to remain competitive. We may not be able to
15
license these products or technologies on commercially reasonable terms or at all. In addition, we may fail to successfully integrate any licensed technology or products into our services. Our inability to obtain any of these licenses could delay our business development until alternative technologies can be identified, licensed and integrated.
Governmental Regulations
Our operations are subject to and affected by various PRC state and local laws and regulations. These laws and regulations include those related to the areas of healthcare, medicine, and foreign investment in medical institutions within China. In particular, our operations are subject to the provisions and regulations under: i) Regulation On Administration of Medical Institutions (the Regulation), established in September 1, 1994; ii) Detailed Rules For Implementation of the Regulation On Administration of Medical Institutions (the Rules), established in September 1, 1994; and iii) Interim Measures for the Administration of Sino-Foreign Equity Joint and Cooperative Joint Medical Institutions (the Interim Measures), established in July 1, 2000. The following discussion provides an overview of the foregoing regulations and the impact they have on our business.
Regulation On Administration of Medical Institutions & Detailed Rules For Implementation of the Regulation On Administration of Medical Institutions
The Regulation On Administration of Medical Institutions & the Detailed Rules For Implementation of the Regulation On Administration of Medical Institutions were collectively established by the PRC government for the purpose of strengthening the administration of medical institutions within China and for promoting the development of medical and public health services in China. Pursuant to the terms of the Regulation, and the accompanying Rules which were promulgated thereunder, prior to engaging in its business operations, Dalian Vitup Healthcare was required to apply for and obtain an Approval Certificate for the Establishment of Medical Institution, from the Public Health Administrative Department of Local Peoples Government above county level (the Public Health Department). Additionally, prior to engaging in the business of providing medical services, Dalian Vitup Healthcare was required to obtain from the Public Health Department a Practice License of Medical Institution.
Currently, pursuant to the Regulation and the Rules, the business operations of Dalian Vitup Healthcare are subject to the supervision of the Public Health Department. In the event that the Public Health Department determines that Dalian Vitup Healthcares business operations are not in compliance with either the Regulations or the Rules, Dalian Vitup Healthcare could be subject to penalties. The penalties include, but are not limited to: i) a penalty if Dalian Vitup Healthcare failed to operate with a valid Practice License of Medical Institution, which could result in a fine of up to RMB 3,000 (US $424); ii) a penalty if Dalian Vitup Healthcare were to sell, lend, or transfer its Practice License of Medical Institution, which could result in a monetary fine of up to RMB 3,000 (US $424); or iii) a penalty if the Dalian Vitup Healthcare were to employ an individual who did not have the requisite qualification certificate of public health technique, which could result in a monetary fine of up to RMB 3,000 (US $424).
Any future medical clinics that we establish will be required to comply with all of the foregoing governmental regulations. Failure to comply with PRC governmental regulations could materially and adversely affect our business and operation and may substantially increase the cost of providing our services.
16
Interim Measures for the Administration of Sino-Foreign Equity Joint and Cooperative Joint Medical Institutions
The Interim Measures for the Administration of Sino-Foreign Equity Joint and Cooperative Joint Medical Institutions were established by the PRC government in July, 2000, for the express purpose of enhancing the administration of Chinese foreign joint equity ventures and cooperative medical institutions, and promoting the development of the medical industry within China. The Interim Measures are supervised by the Ministry of Health and the Ministry of Foreign Trade and Economic Cooperation (MOFTEC) and are administered by an Administrative Department of Health at the municipal level. The Interim Measures establish the protocols and procedures for the implementation of either a Chinese-foreign joint venture or a cooperative medical institution. Pursuant to the Interim Measures, any party seeking to establish either a Chinese-foreign joint venture or cooperative medical institution must go through the application process set forth in the Interim Measures, and must ultimately obtain approval from the Ministry of Health and MOFTEC for the contemplated joint venture. Once the joint venture is approved, the joint venture is subject to both the Regulation On Administration of Medical Institutions & the Detailed Rules For Implementation of the Regulation On Administration of Medical Institutions, discussed above. Dalian Vitup Healthcare received the approval required under the Interim Measures for the Administration of Sino-Foreign Equity Joint and Cooperative Joint Medical Institutions on April 1, 2004.
Employees
The Company and its operating affiliates currently have one hundred and seven (107) full-time employees. Forty-five (45) of the current employees hold medical degrees from universities throughout China.
Reports to Security Holders
We are subject to the informational requirements of the Securities Exchange Act of 1934 which requires us to file reports, proxy statements and other information with the Securities and Exchange Commission. Such reports, proxy statements and other information may be inspected at public reference facilities of the SEC at 100 F Street, NE, Room 1580, Washington D.C. 20549. Copies of such material can be obtained from the Public Reference Section of the SEC at 100 F Street, NE, Room 1580, Washington, D.C. 20549 at prescribed rates. The public could obtain information on the operation of the public reference room by calling the Securities and Exchange Commission at 1-800-SEC-0330. Because we file documents electronically with the SEC, you may also obtain this information by visiting the SEC's Internet website at http://www.sec.gov.
ITEM 1A. RISK FACTORS.
Not Applicable
ITEM 1B. UNRESOLVED STAFF COMMENTS.
Not Applicable
ITEM 2.
PROPERTIES.
17
Medical Clinic
On January 12, 2004, the Registrants operating affiliate, Dalian Vitup Healthcare entered into a House Lease Agreement with Shubin Wang for the lease of a portion of the premises housing its medical clinic. Pursuant to the terms of the House Lease Agreement, Dalian Vitup Healthcare leased a portion of the property located at No. 108-1, 108-2, Nanshan Road, Zhongshan District, Dalian for a period of 15 years at an initial annual rental rate of RMB 100,000 (approximately US$13,835.30). Pursuant to the terms of the House Lease Agreement, the lease is for a term of 15 years, the lease is not cancelable, and the annual rental rate will be adjusted every two years through consultation between the parties. Additionally, under the House Lease Agreement, Dalian Vitup Healthcare is responsible for the payment of all taxes, expenses and other relevant charges arising out their occupation of the leased premises. A copy of the House Lease Agreement was filed as Exhibit 10.8 to the Companys Form 10 filed with the Securities and Exchange Commission on May 1, 2008, and is herein incorporated by reference. On March 12, 2006, the parties agreed to adjust the annual rental rate in the House Lease Agreement to RMB 348,000 (approximately US$49,983.40), effective April 2006. A copy of the Supplemental House Lease Agreement with the information relating to the adjustment of the annual rental rate was filed as Exhibit 10.15 to the report on Form 10-K filed with the SEC on April 15, 2009, and is herein incorporated by reference.
On August 15, 2006, Dalian Vitup Management entered into a House Lease Agreement with Shubin Wang for the lease of office space. Pursuant to the terms of the House Lease Agreement, Dalian Vitup Management leased a portion of the property located at No. 108-1, 108-2, Nanshan Road, Zhongshan District, Dalian for a period of 20 years at an annual rental rate of RMB 5,800 (approximately US$833). Pursuant to the terms of the House Lease Agreement, the lease is not cancelable, and the annual rental rate will be adjusted every two years through consultation between the parties. Additionally, under the House Lease Agreement, Dalian Vitup Management is responsible for the payment of all taxes, expenses and other relevant charges arising out their occupation of the leased premises. The foregoing description of the House Lease Agreement is qualified in its entirety by reference to the House Lease Agreement which is filed as Exhibit 10.16 to the report on Form 10-K filed with the SEC on April 15, 2009, and is herein incorporated by reference.
Mobile Medical Check-up Facility
Our operating affiliate operates a mobile medical check-up facility which is based at its facility in Dalian. The mobile medical facility is located in a converted passenger bus and is designed to provide the Company with the ability to offer its medical check-up services on-site at its various customers business operations and factories. The mobile clinic contains a variety of modern medical equipment.
Equipment
Within our medical clinic and mobile medical facilities, our operating affiliates own and utilize a variety of modern medical devices for diagnosis and treatment, including, but not limited to: a) a Quantum Resonance Spectrometer; b) an Acuson Aspen Siemens Color Ultrasound System; c) an Osteospace; d) a Body Composition Analyzer; e) a Blood Lead Detector; f) a Remote Control X-Ray System; g) an Automatic Biochemical Analyzer; and h) a Japanese Full Automatic Blood Cell Counter.
ITEM 3.
LEGAL PROCEEDINGS.
18
The Company is not a party to any pending legal proceedings, and no such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation.
ITEM 4.
(REMOVED AND RESERVED)
PART II
ITEM 5.
MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
The Registrant's common stock is approved for quotation on the Over the Counter Bulletin Board under the symbol CVPH. However, there is no established or liquid trading market for the Companys shares because very limited, if any, trading has occurred with the Companys common stock over the last two fiscal years. The Registrant currently has 15,000,000 shares of common stock issued and outstanding.
The following table sets forth the high and low bid prices of our common stock (USD) for the last two fiscal years and subsequent interim periods, as reported by the National Quotation Bureau and represents inter dealer quotations, without retail mark-up, mark-down or commission and may not be reflective of actual transactions:
| (U.S. $) | |
|
|
|
2008 | HIGH | LOW |
Quarter Ended March 31 | $2.05 | $0.20 |
Quarter Ended June 30 | $1.75 | $0.35 |
Quarter Ended September 30 | $1.25 | $0.10 |
Quarter Ended December 31 | $1.35 | $0.50 |
2009 | HIGH | LOW |
Quarter Ended March 31 | $2.00 | $0.50 |
Quarter Ended June 30 | $2.00 | $2.00 |
Quarter Ended September 30 | $2.00 | $0.015 |
Quarter Ended December 31 | $1.00 | $0.98 |
Holders
The Registrant currently has 15,000,000 shares of common stock issued and outstanding. As of March 30, 2010, the Registrants stock was owned by approximately 40 holders of record.
Dividends
The Company has not declared or paid any cash dividends on its common stock during the fiscal years ended December 31, 2009 or 2008. There are no restrictions on the common stock that limit the
19
ability of us to pay dividends if declared by the Board of Directors and the loan agreements and general security agreements covering the Companys assets do not limit its ability to pay dividends. The holders of common stock are entitled to receive dividends when and if declared by the Board of Directors, out of funds legally available therefore and to share pro-rata in any distribution to the stockholders. Generally, the Company is not able to pay dividends if after payment of the dividends, it would be unable to pay its liabilities as they become due or if the value of the Companys assets, after payment of the liabilities, is less than the aggregate of the Companys liabilities and stated capital of all classes.
Equity Compensation Plan
We do not have an equity compensation plan.
ITEM 6.
SELECTED FINANCIAL DATA.
Not Applicable.
ITEM 7.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION.
SPECIAL NOTE OF CAUTION REGARDING FORWARD-LOOKING STATEMENTS
CERTAIN STATEMENTS IN THIS REPORT, INCLUDING STATEMENTS IN THE FOLLOWING DISCUSSION, ARE WHAT ARE KNOWN AS "FORWARD LOOKING STATEMENTS", WHICH ARE BASICALLY STATEMENTS ABOUT THE FUTURE. FOR THAT REASON, THESE STATEMENTS INVOLVE RISK AND UNCERTAINTY SINCE NO ONE CAN ACCURATELY PREDICT THE FUTURE. WORDS SUCH AS "PLANS," "INTENDS," "WILL," "HOPES," "SEEKS," "ANTICIPATES," "EXPECTS "AND THE LIKE OFTEN IDENTIFY SUCH FORWARD LOOKING STATEMENTS, BUT ARE NOT THE ONLY INDICATION THAT A STATEMENT IS A FORWARD LOOKING STATEMENT. SUCH FORWARD LOOKING STATEMENTS INCLUDE STATEMENTS CONCERNING OUR PLANS AND OBJECTIVES WITH RESPECT TO THE PRESENT AND FUTURE OPERATIONS OF THE COMPANY, AND STATEMENTS WHICH EXPRESS OR IMPLY THAT SUCH PRESENT AND FUTURE OPERATIONS WILL OR MAY PRODUCE REVENUES, INCOME OR PROFITS. NUMEROUS FACTORS AND FUTURE EVENTS COULD CAUSE THE COMPANY TO CHANGE SUCH PLANS AND OBJECTIVES OR FAIL TO SUCCESSFULLY IMPLEMENT SUCH PLANS OR ACHIEVE SUCH OBJECTIVES, OR CAUSE SUCH PRESENT AND FUTURE OPERATIONS TO FAIL TO PRODUCE REVENUES, INCOME OR PROFITS. THEREFORE, THE READER IS ADVISED THAT THE FOLLOWING DISCUSSION SHOULD BE CONSIDERED IN LIGHT OF THE DISCUSSION OF RISKS AND OTHER FACTORS CONTAINED IN THIS REPORT ON FORM 10-K AND IN THE COMPANY'S OTHER FILINGS WITH THE SECURITIES AND EXCHANGE COMMISSION. NO STATEMENTS CONTAINED IN THE FOLLOWING DISCUSSION SHOULD BE CONSTRUED AS A GUARANTEE OR ASSURANCE OF FUTURE PERFORMANCE OR FUTURE RESULTS.
Overview
China Vitup Health Care Holdings, Inc., a Nevada corporation is a holding company which, through its wholly-owned subsidiaries and operating affiliates, is engaged in the business of providing
20
healthcare services to customers in China. Presently, the Registrant has an affiliate relationship with a single medical clinic which is a 24,200 square foot facility located in Dalian, China, through which it offers integrated healthcare services designed specifically to fit the needs of the Chinese population. At the clinic in Dalian, the Registrants operating affiliate both monitors the health of its patients through regularly scheduled check-ups, and works to diagnose its patients different ailments and establish appropriate treatment procedures for such ailments. Since the facility in Dalian is primarily a preventative care facility patients who require medical treatment which is more than preventative in nature are referred to hospitals and other health facilities.
Our operating affiliate offers integrated health management services designed specifically for the PRC population through its preventative care medical facility located in the city of Dalian, China. The health services offered at our operating affiliates medical facility includes physical examinations, health management plans, and guidance for medical treatment. Our operating affiliates assists its patients in maintaining a healthy status by comprehensively monitoring, analyzing and evaluating the patients and by predicting various risk factors that affect the health and well being of its patients. In many instances our operating affiliate, as primary checkup facilities, will refer its patients to specialized hospitals and health facilities throughout the world which are equipped to treat the Companys patients specific health problems and needs that the Company has identified through its comprehensive checkup and monitoring procedures.
Within the next three years, it is our objective is to establish an additional three affiliated medical clinics throughout China through which we are able to provide high quality medical care to Chinese citizens. We will model our clinics after the clinic that we currently operate in Dalian. We anticipate establishing medical clinics in the following cities, in the following order: 1) Beijing; and 2) Shenyang. At proper time, we are going to copy our business model quickly and open more new clinics in economic developed cities all around China.
Results of Operations
The following discussion and analysis provides information that we believe is relevant to an assessment and understanding of our results of operation and financial condition for the fiscal years ended December 31, 2009 and 2008. The following discussion should be read in conjunction with the Financial Statements and related Notes appearing elsewhere in this Form 10-K.
Our financial statements are stated in US Dollars and are prepared in accordance with generally accepted accounting principals of the United States (GAAP).
Results of Operations for the Fiscal Year Ended December 31, 2009 Compared to the Fiscal Year Ended December 31, 2008
Revenues
During the fiscal year ended December 31, 2009, the Company had total operating revenue in the amount of $2,411,043. Of this $2,271,236 was directly attributable to revenue generated from the Companys healthcare management service, and $139,807 was attributable to the Companys Chinese medical service.
During the fiscal year end December 31, 2008, the Company had total operating revenue in the amount of $2,033,156. Of this $1,918,494 was directly attributable to revenue generated from the Companys healthcare management service, and $114,662 was attributable to the Companys Chinese
21
medical service.
The increase in total operating revenue from 2008 to 2009 was primarily due to the increase in the number of individual customers utilizing and paying for our healthcare management service. The increase in individual customers was primarily attributable to promotional efforts from the Companys marketing department.
There are three major types of customers: Individuals and Members, Enterprises including Government Agencies, and General Treatment. For different type of customers, there is different unit price. Each types proportion of the total is 38%, 56%and 6%, respectively.
The following chart illustrates the changes which occurred regarding the percent and amount of the Companys revenue attributable to each customer type for the fiscal years ended December 31, 2009 and 2008:
| Fiscal Years Ended 2008 and 2009 | |||||
Customer Type | 2009 ($) | % of Total | 2008 ($) | % of Total | Change | % Change |
Individuals & Members | 907,013 | 38% | 427,742 | 21% | 479,271 | 112% |
Enterprises( including Government Agencies) | 1,364,223 | 56% | 1,458,694 | 72% | -94,471 | -6% |
Insurance Companies | 0 | 0% | 38,504 | 2% | -38,504 | -100% |
General Treatment | 139,807 | 6% | 108,216 | 5% | 31,591 | 29% |
TOTAL | 2,411,043 | 100% | 2,033,156 | 100% | 377,887 | 19% |
The Company’s operating revenue from Individuals & Members and General Treatment for the fiscal year ended December 31, 2009 increased by $479,271 and $31,591, or approximately 112% and 29%, respectively as compared to the fiscal year ended December 31, 2008.
The following chart illustrates the changes in our revenue generated by our health management service and Chinese medical service for the fiscal year ended December 31, 2009, as compared to the fiscal year ended December 31, 2008:
|
| Year ended December 31, | ||||
|
| 2009 |
| 2008 |
| % Change |
Health management service revenue: |
|
|
|
|
|
|
- Product sale |
| - |
| - |
| - |
- Service revenue |
| $2,271,236 |
| $1,918,494 |
| 18% |
|
|
|
|
|
|
|
Total Health management service revenue: |
| $2,271,236 |
| $1,918,494 |
| 18% |
|
| Year ended December 31, | ||||
|
| 2009 |
| 2008 |
| % Change |
Chinese medical service revenue: |
|
|
|
|
|
|
- Product sale |
| $58,317 |
| $82,522 |
| -29% |
- Service revenue |
| $81,490 |
| $32,140 |
| 154% |
|
|
|
|
|
|
|
Total Chinese medical service revenue |
| $139,807 |
| $114,662 |
| 22% |